Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine adjunct treatment with morphine in ventilated preterm babies
ISRCTN24287322Phase 4Recruiting
- Sponsor
- University Hospitals of Derby and Burton
- Start
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of dexmedetomidine and morphine in pain, sponsored by University Hospitals of Derby and Burton. Primary endpoint: Cumulative morphine dose over 120 hours. Started Mar 2026; status: recruiting.
02
Drugs
dexmedetomidinemorphine
03
Conditions
pain
Beyond the preview
Go deeper on ISRCTN24287322.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN24287322.